Common use of PRODUCT ACCEPTANCE Clause in Contracts

PRODUCT ACCEPTANCE. 3.7.1 The Product supplied by Dexcel to Kitov shall correspond to the respective Product Specifications and the relevant Marketing Authorization and shall be manufactured in compliance with cGMP and the Quality Agreement. 3.7.2 Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an “Apparent Defect”), such notification to be provided within thirty (30) Working Days of receipt of the Product at Kitov’s warehouse, accompanied by samples of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolved. In the event that a defect is not apparent upon visual inspection during the shelf life of the Product (“Hidden Defect”), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the same, to be accompanied by samples of any such allegedly defective Product, if such samples are available In the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it shall be deemed as Kitov having accepted the relevant consignment. 3.7.3 Dexcel shall use its best efforts to make up any shortfall in shipment quantity as soon as practicable after being notified by Kitov of such shortfall. In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after receipt of the samples to show that the Product in question meets the Specifications (“Period”). In the event that no agreement is reached by the end of the Period, Kitov shall have the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), and Dexcel shall require proof that Kitov has destroyed that part or all of the original shipment with claimed defective Product. In the event that Kitov has fully paid the Supply Price for the claimed defective Product, Dexcel shall supply the Replacement Shipment at no additional Transfer Price. In the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications). 3.7.4 Dexcel’s responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement of the Product or the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement. 3.7.5 In the event that the Parties do not agree on whether the Product meets the Specifications by the end of the Period, the Parties agree to nominate an independent, reputable laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Parties. The result shall be binding upon both Parties. Any charges for such examination shall be borne by the Party found to be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel for the Replacement Shipment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specifications, Kitov shall have to pay for both shipments.

Appears in 3 contracts

Sources: Product Manufacturing Agreement, Product Manufacturing Agreement (Kitov Pharma Ltd.), Product Manufacturing Agreement (Kitov Pharma Ltd.)

PRODUCT ACCEPTANCE. 3.7.1 The Product supplied 8.1 SANO shall manufacture the Licensed Products and make them available for pickup by Dexcel to Kitov shall correspond PPI in accordance with all applicable laws, rules and regulations including, without limitation, the Specifications applicable to the respective Licensed Product in question, Current Good Manufacturing Practices of the FDA (as the same may change from time to time) and all other applicable requirements of the FDA and other governmental authorities having jurisdiction. 8.2 All Licensed Products made available for pick up by PPI shall be accompanied by quality control certificates of analysis signed by a duly authorized laboratory official of SANO confirming that each batch of Licensed Product covered by such certificate meets its release Specifications and the relevant Marketing Authorization and shall be manufactured deemed accepted by it unless PPI, acting reasonably and in compliance with cGMP and good faith, shall give written notice of rejection (hereafter referred to as a "Rejection Notice") to SANO within 35 days after pick up of the Quality AgreementLicensed Products by, on behalf of or for the account of PPI at SANO's facility. 3.7.2 Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based The Rejection Notice shall state in reasonable detail (sufficient to enable SANO to identify the nature of the problem and the tests or studies to be conducted by or on its behalf to confirm or dispute same) the reason why the Licensed Products are not acceptable to PPI. If the Licensed Products meet the applicable provisions of Section 8.1 and are in quantities specified in a purchase order, PPI shall not be entitled to reject them. Any Rejection Notice shall be accompanied by copies of all written reports relating to tests, studies or investigations performed to that date by or for PPI on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or Licensed Product batch rejected. (b) any failure Upon receipt of such Rejection Notice, SANO may require PPI to return the rejected Licensed Products or samples thereof to SANO for further testing, in which event such Licensed Products or samples thereof, as the case may be, shall be returned by PPI to SANO or, at SANO's direction, at SANO's expense. If it is later determined by the parties or by an independent laboratory or consultant that PPI was not justified in rejecting the Licensed Products or that PPI or its Affiliates were the cause of or were responsible for the problem, PPI shall reimburse SANO for the costs of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing return, as well as any other costs or expenses incurred by SANO as a result of the Product delivered to it by Dexcel rejection or return. (each of (ac) and (b) being an “Apparent Defect”)PPI's test results or basis for rejection shall be conclusive unless SANO notifies PPI, such notification to be provided within thirty (30) Working Days 30 days of receipt by SANO of the Product at Kitov’s warehouserejected Licensed Products or samples or such longer periods of time as may be reasonable in the circumstances to enable SANO to conduct (and receive the results of) the appropriate tests, accompanied by samples of any studies or investigations which SANO should reasonably conduct to confirm the problem in question and to identify the source thereof, that it disagrees with such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolved. In test results or its responsibility for the event that a defect is not apparent upon visual inspection during the shelf life of the Product (“Hidden Defect”), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the same, to be accompanied by samples of any such allegedly defective Product, if such samples are available In the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it shall be deemed as Kitov having accepted the relevant consignment. 3.7.3 Dexcel shall use its best efforts to make up any shortfall problem in shipment quantity as soon as practicable after being notified by Kitov of such shortfallquestion. In the event of Product which Kitov claims have Apparent Defects or Hidden Defectssuch a notice by SANO, Dexcel shall have up to thirty (30) Working Days after receipt representative samples of the samples to show that batch of the Licensed Product in question meets shall be submitted to a mutually acceptable independent laboratory or consultant (if not a laboratory analysis issue) for analysis or review, the Specifications costs of which shall be paid by the party that is determined by the independent laboratory or consultant to have been responsible for the rejection. (“Period”)d) If a Licensed Product is rejected by PPI, PPI's duty to pay the amount payable to SANO pursuant to Section 7.2 hereof in respect of the rejected Licensed Product shall be suspended until such time as it is determined (I) by an independent laboratory or consultant that the Licensed Product in question should not have been rejected by PPI or (II) by the parties or by any arbitration conducted pursuant hereto or by a final order of a court of competent jurisdiction (which is not subject to further appeal) that any act or omission of, on behalf of or for which PPI or its Affiliates is responsible was the cause of the problem that was the basis for the rejection. If only a portion of an order is rejected, only the duty to pay the amount allocable to such portion shall be suspended. 8.3 In the event any Licensed Products are appropriately rejected by PPI (being Licensed Products that no agreement is reached do not meet the applicable provisions of Section 8.1 other than as a result of any act or omission by PPI or its Affiliates), SANO shall replace such Licensed Products with conforming goods or, if requested by PPI, shall provide a credit to PPI for the end amount, if any, previously paid by PPI to SANO on account of the Period, Kitov Licensed Products in question. The credit shall have be provided by SANO to PPI immediately following the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), and Dexcel shall require proof that Kitov has destroyed that part or all expiry of the original shipment with claimed defective Productperiod during which SANO may dispute a Rejection Notice as contemplated in Section 8.2(c) above (unless the Rejection Notice is disputed by SANO, in which event such credit shall be given only if the dispute is resolved in favor of PPI). In the event that Kitov Replacement Licensed Products, as aforesaid, shall be delivered to PPI at no cost to PPI if PPI has fully already paid the Supply Price for the claimed defective Productrejected Licensed Products and not received a credit therefor, Dexcel shall supply as aforesaid. All delivery costs, including insurance, incident to the Replacement Shipment at no additional Transfer Price. In return of Licensed Products to SANO and delivery of the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications). 3.7.4 Dexcel’s responsibility for Product supplied by it replacement Licensed Products to Kitov failing to meet the Specifications PPI's Spring Valley facility shall be limited to the replacement of the Product or the refund of the Supply Price paid by Kitov for such orderSANO, as agreed by unless the partiesrejection is determined not to have been appropriately rejected, except as otherwise provided under this Agreementin which case the last sentence of Section 8.2(a) shall apply. 3.7.5 In the event that the Parties do not agree on whether the Product meets the Specifications by the end of the Period, the Parties agree to nominate an independent, reputable laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Parties. The result shall be binding upon both Parties. Any charges for such examination shall be borne by the Party found to be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel for the Replacement Shipment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specifications, Kitov shall have to pay for both shipments.

Appears in 2 contracts

Sources: Distribution Agreement (Pharmaceutical Resources Inc), Distribution Agreement (Sano Corp)

PRODUCT ACCEPTANCE. 3.7.1 PRODUCT is subject to Company's acceptance testing to assure conformance to specifications. Supplier shall submit two (unless another number is mutually agreed to) production samples of PRODUCT (referred to herein collectively as or "sample(s)") produced in a continuous run on permanent production tooling to a location designated by Company for examination. Company shall evaluate samples and issue a written acceptance or rejection to Supplier within forty five (45) days after receipt of samples. The Product supplied failure by Dexcel Company to Kitov reject with cause within such time shall correspond constitute acceptance. Any rejection shall identify the failure to meet specifications in reasonable detail sufficient to allow Supplier to correct the respective Product Specifications and the relevant Marketing Authorization and shall be manufactured in compliance with cGMP and the Quality Agreement. 3.7.2 Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger deficiency. RESTRICTED - PROPRIETARY INFORMATION The information following compliance with the provisions contained herein is for use by authorized employees of the Quality Agreementparties hereto only and is not for general use or distribution within or outside of their respective companies except under written agreement. If a sample evaluated pursuant to this Section is rejected, and/or (b) any Supplier agrees to correct, at its expense, the failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered specifications (referred to it by Dexcel (each of (aherein collectively as "defect") leading to such rejection and (b) being an “Apparent Defect”), such notification resubmit a corrected sample to be provided Company within thirty (30) Working Days of days after receipt of notice from Company of such defect (collectively referred to herein as the Product at Kitov’s warehouse, accompanied by samples of any such allegedly defective Product and any such Product "Corrective Period"). Company shall not be removed from quarantine until their status is resolved. In the event that a defect is not apparent upon visual inspection during the shelf life of the Product (“Hidden Defect”), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within have thirty (30) Working Days days after the resubmitting of discovering the same, corrected sample to be accompanied by samples of any accept or reject such allegedly defective Product, if such samples deliverable. If the defects in a rejected sample are available In the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect not corrected within the respective aforementioned periods, it shall be deemed as Kitov having accepted Corrective Period or if a resubmitted sample re-tested or re-evaluated by Company during the relevant consignment. 3.7.3 Dexcel shall use its best efforts to make up any shortfall in shipment quantity as soon as practicable after being notified by Kitov of such shortfall. In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after receipt day re-evaluation period is again rejected, Company may at its option: (a) accept the sample as is; (b) afford Supplier one or more correction extensions; or (c) terminate the applicable SPA and purchase orders issued hereunder without any cost or charge to Company whatsoever, including costs or charges incurred by Supplier in procuring equipment, material and special tooling to perform any part of this Agreement, loss of profits or labor, and materials expended in the production of samples. If Company opts to perform testing at Supplier's facility, Supplier shall allow Company to send a representative(s) to observe and participate in the testing. Supplier shall not make any shipments under this Agreement prior to correction of defects and approval of the production samples. Company will return samples to show that the Product in question meets the Specifications (“Period”). In the event that no agreement is reached by the end of the Period, Kitov shall have the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), and Dexcel shall require proof that Kitov has destroyed that part or all of the original shipment with claimed defective Product. In the event that Kitov has fully paid the Supply Price for the claimed defective Product, Dexcel shall supply the Replacement Shipment at no additional Transfer Price. In the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications)Supplier. 3.7.4 Dexcel’s responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement of the Product or the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement. 3.7.5 In the event that the Parties do not agree on whether the Product meets the Specifications by the end of the Period, the Parties agree to nominate an independent, reputable laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Parties. The result shall be binding upon both Parties. Any charges for such examination shall be borne by the Party found to be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel for the Replacement Shipment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specifications, Kitov shall have to pay for both shipments.

Appears in 1 contract

Sources: General Agreement for the Procurement of Products and Services and the Licensing of Software (Vina Technologies Inc)

PRODUCT ACCEPTANCE. 3.7.1 The 12.1 All shipments of Product supplied by Dexcel to Kitov shall correspond to the respective Product Specifications and the relevant Marketing Authorization and shall be manufactured deemed accepted by Customer unless Customer, acting reasonably and in compliance with cGMP and good faith, gives written notice of rejection (hereafter referred to as a “Rejection Notice”) to DSM within ** (i) after delivery of such Product or, (ii) where the Quality Agreement. 3.7.2 Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an “Apparent Defect”), such notification defect is unable to be provided within thirty (30) Working Days discovered at such time, after discovery by Customer of receipt such defect where Customer can establish with reasonably competent and credible evidence with reasonable certainty that the defect resulted from DSM’s breach of its obligations and existed at the Product at Kitov’s warehouse, accompanied by samples time of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolved. In the event that a defect is not apparent upon visual inspection during the shelf life delivery of the Product (the “Hidden DefectRejected Product”). Subject to the provisions of Section 12, Kitov Customer has the right to reject and return, at the expense of DSM, any portion of any shipment of Rejected Product, without invalidating any remainder of such shipment. 12.2 The Rejection Notice shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering state in reasonable detail the same, to reason why the Product is rejected. Any Rejection Notice shall be accompanied by copies of all written reports relating to tests, studies or investigations performed to that date by or for Customer on the Rejected Product. Customer shall also have the right to report any shortages in shipment in such Rejection Notice, 12.3 Upon receipt of such Rejection Notice and DSM’s written request, Customer shall return, at DSM’s sole expense, the Rejected Product or samples thereof to DSM. Title to and risk of any such allegedly defective loss associated with the Rejected Product shall transfer to DSM upon delivery of the Rejected Product to a carrier. **. If it is later determined by the parties or by an independent laboratory or consultant mutually agreed to by the parties that Customer was unreasonable in rejecting the Rejected Product, if such samples are available In the event of any failure **, as evidenced by Kitov to provide Dexcel with written notification of any such shortfalladequate documentation. If it is determined that Customer’s rejection was reasonable, Apparent Defect **. 12.4 The test results or Hidden Defect within the respective aforementioned periods, it basis for rejection generated by Customer (or a Third Party Designee) shall be deemed as Kitov having accepted conclusive, unless DSM (acting reasonably and in good faith) notifies Customer, within ** of receipt by DSM of the relevant consignment. 3.7.3 Dexcel shall use its best efforts to make up any shortfall in shipment quantity as soon as practicable after being notified by Kitov of Rejection Notice that it disagrees with such shortfalltest results. In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after Customer’s receipt of such a notice, representative samples of the samples to show that batch of the Rejected Product in question meets the Specifications (“Period”). In the event that no agreement is reached by the end of the Period, Kitov shall have the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), and Dexcel shall require proof that Kitov has destroyed that part or all of the original shipment with claimed defective Product. In the event that Kitov has fully paid the Supply Price for the claimed defective Product, Dexcel shall supply the Replacement Shipment at no additional Transfer Price. In the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications). 3.7.4 Dexcel’s responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited submitted to a mutually acceptable independent laboratory or consultant (if not a laboratory analysis issue) for analysis or review, the replacement costs of which shall ultimately be paid (i) by Customer should the independent laboratory or consultant determine that Customer’s rejection of the Product was unreasonable or (ii) by DSM should the refund independent laboratory or consultant determine that Customer’s rejection of the Supply Price paid Product was reasonable. The findings of the laboratory or consultant shall be final and conclusively binding on the parties as to whether the rejection was justified, absent manifest error. 12.5 If any Product is rejected by Kitov for Customer, Customer’s duty to pay all amounts payable to DSM in respect of the Rejected Product shall be (i) suspended until such ordertime as it is determined by an independent laboratory or consultant that the Products in question were unreasonably rejected by Customer or (ii) waived and null and void if it is determined by an independent laboratory or consultant that the Rejected Products were reasonably rejected by Customer. If only a portion of an order is rejected, only the duty to pay the amount allocable to such portion shall be suspended or waived, as agreed by the parties, except as otherwise provided under this Agreementapplicable. 3.7.5 In the event that the Parties do not agree on whether the Product meets the Specifications by the end of the Period, the Parties agree to nominate an independent, reputable laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Parties. The result shall be binding upon both Parties. Any charges for such examination shall be borne by the Party found to be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel for the Replacement Shipment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specifications, Kitov shall have to pay for both shipments.

Appears in 1 contract

Sources: Manufacturing and Supply Agreement (Cti Biopharma Corp)

PRODUCT ACCEPTANCE. 3.7.1 The Product supplied by Dexcel to Kitov shall correspond to the respective Product Specifications and the relevant Marketing Authorization and shall be manufactured in compliance with cGMP and the Quality Agreement. 3.7.2 Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an “Apparent Defect”), such notification to be provided within Within thirty (30) Working Days days of receipt of the Product at Kitov’s warehouseProduct, accompanied by SaSy or its designee shall conduct an analysis of samples of Products delivered by Banner. Should the result of any analysis of such allegedly defective Product samples deviate from the Banner Manufacturing Requirements, SaSy shall notify Banner in writing by facsimile and any such Product shall not be removed from quarantine until their status is resolved. In the event that a defect is not apparent upon visual inspection during the shelf life immediately thereafter provide Banner with samples of the Product (“Hidden Defect”)tested. If, Kitov following a review of the test results and after conducting its own test of the samples, Banner agrees that such samples do not conform to the Banner Manufacturing Requirements, Banner shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the sameSaSy, to be accompanied by samples free of any such allegedly defective additional charge, with new deliveries of the same quantity of the Products and pay for the cost of any related shipping, removal or destruction. At Banner's cost, Banner may promptly reinspect the nonconforming Product to determine whether it meets the Banner Manufacturing Requirements. In either event, SaSy shall return, at Banner's expense, the particular lot or shipment of the Product which does not comply with the Banner Manufacturing Requirements if requested to do so by Banner. If SaSy fails to notify Banner of a batch that fails to conform to Banner Manufacturing Requirements by the thirty-fifth (35th) day following [***]-Confidential Treatment Requested receipt of the Product, if such samples are available In the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it then SaSy shall be deemed as Kitov having to have accepted the relevant consignmentsuch batch. 3.7.3 Dexcel shall use its best efforts to make up any shortfall in shipment quantity as soon as practicable after being notified by Kitov of such shortfall. In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30b) Working Days after receipt of the samples to show that the Product in question meets the Specifications (“Period”). In the event that no agreement is reached by the end of the Period, Kitov shall have the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), If Banner and Dexcel shall require proof that Kitov has destroyed that part or all of the original shipment with claimed defective Product. In the event that Kitov has fully paid the Supply Price for the claimed defective Product, Dexcel shall supply the Replacement Shipment at no additional Transfer Price. In the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications). 3.7.4 Dexcel’s responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement of the Product or the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement. 3.7.5 In the event that the Parties SaSy do not agree on whether the Product meets conforms to the Specifications by the end of the PeriodBanner Manufacturing Requirements, the Parties agree matter will be submitted to nominate an independent, reputable independent testing laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Partiesparties for its review and determination. The result shall parties will agree on the analytical methods and procedures for testing and an inter-laboratory methods transfer process will be implemented at the laboratory to ensure acceptable data. The determination of such independent laboratory will be binding upon on both Partiesparties. Any charges for such examination The cost of the independent laboratory shall be borne by the Party found party whose testing results were in error. If the product is determined not to conform to the Banner Manufacturing Requirements, then Banner shall, subject to Sections 11.2 and 11.5 have the obligations with respect to the non-conforming Product set forth in Section 5.3(a) above; provided, however, that Banner shall be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel responsible for the Replacement Shipmentcost of any lost or damaged Core (at $[***] per 1,000 Cores) that may be necessary in order to replace any non-conforming Products. In Notwithstanding the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specificationsforegoing, Kitov Banner shall have no liability with respect to non-conforming Products to the extent that such Products do not conform to the Banner Manufacturing Requirements because of a defect in the Core or any other ingredients supplied by SaSy under this Agreement. If the Product is determined to conform to the Banner Manufacturing Requirements, then SaSy shall accept and pay for both shipmentsthe Product in accordance with the terms hereof. (c) Subject to Sections 11.2 and 11.5, Banner's obligations in this Section 5.3 shall constitute SaSy's sole remedy for delivery of Product that does not conform to Banner Manufacturing Requirements.

Appears in 1 contract

Sources: Supply Agreement (First Horizon Pharmaceutical Corp)

PRODUCT ACCEPTANCE. 3.7.1 The Product supplied by Dexcel to Kitov shall correspond (A) Prior to the respective shipment of any Product Specifications for First Commercial Sale, members of OCD and the relevant Marketing Authorization SNBTS’ quality organizations will review OCD’s written criteria for incoming quality inspections and performance testing measures (“Incoming Testing”) that OCD shall use to accept or reject Product. Additionally, Product batches will be manufactured released for sale as specified in compliance with cGMP and the Quality AgreementSystem Agreement between SNBTS and OCD. 3.7.2 Kitov (B) SNBTS shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an “Apparent Defect”), such notification test or cause to be provided within thirty (30) Working Days tested each lot of receipt of the Product at Kitov’s warehouse, accompanied by samples of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolvedProducts pursuant to this Umbrella Agreement before delivery to OCD. In the event that a defect is not apparent upon visual inspection during the shelf life of the Product (“Hidden Defect”), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the same, to Each lot must be accompanied by samples a certificate of analysis, as a minimum, as defined in the Quality System Agreement between SNBTS and OCD. Additional documentation requirements may be stated in a specific Product Attachment. Unless otherwise agreed upon between the parties, or as stated in a specific Product Attachment, SNBTS shall send such documentation to OCD along with delivery of Products. OCD is entitled to rely on such documentation for all purposes of this Umbrella Agreement. Nothing in this Umbrella Agreement shall be construed to require OCD to perform any Incoming Testing on any Products received from SNBTS. (C) SNBTS will retain a representative sample (the “Library Sample”) of each lot of the Products sold to OCD for the duration of time specified in the Quality System Agreement. Each Product Attachment shall specify a time period for OCD to perform Incoming Testing on the Products to determine if they conform to the Product Requirements, are free from defects in material and workmanship, and otherwise comply with the warranties set forth in Article 19.0 (Representations and Warranties) and, on the basis of such allegedly defective Productinspection, if such samples are available In accept or reject the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it shipment. OCD shall be deemed as Kitov having to have accepted the relevant consignment. 3.7.3 Dexcel shall use its best efforts to make up any shortfall in shipment quantity Products supplied by SNBTS as soon as practicable after being notified by Kitov of such shortfall. In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after receipt of the samples to show that the Product in question meets the Specifications (“Period”). In the event that no agreement is reached by the end of the Period, Kitov shall have the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), free from damage and Dexcel shall require proof that Kitov has destroyed that part or all of the original shipment with claimed defective Product. In the event that Kitov has fully paid the Supply Price for the claimed defective Product, Dexcel shall supply the Replacement Shipment at no additional Transfer Price. In the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment defects and are in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications). 3.7.4 Dexcel’s responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement terms of the Product relevant order in all respects unless OCD notifies SNBTS of any damage, defect, or discrepancy within the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement. 3.7.5 In the event that the Parties do not agree on whether time period specified in the Product meets the Specifications by the end of the Period, the Parties agree to nominate an independent, reputable laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Parties. The result shall be binding upon both Parties. Any charges for such examination shall be borne by the Party found to be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel for the Replacement Shipment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specifications, Kitov shall have to pay for both shipmentsAttachment.

Appears in 1 contract

Sources: Supply Umbrella Agreement (Quotient LTD)

PRODUCT ACCEPTANCE. 3.7.1 The Product supplied by Dexcel to Kitov shall correspond (A) Prior to the respective shipment of any Product Specifications for First Commercial Sale, members of OCD and the relevant Marketing Authorization SNBTS’ quality organizations will review OCD’s written criteria for incoming quality inspections and performance testing measures (“Incoming Testing”) that OCD shall use to accept or reject Product. Additionally, Product batches will be manufactured released for sale as specified in compliance with cGMP and the Quality AgreementSystem Agreement between SNBTS and OCD. 3.7.2 Kitov (B) SNBTS shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an “Apparent Defect”), such notification test or cause to be provided within thirty (30) Working Days tested each lot of receipt of the Product at Kitov’s warehouse, accompanied by samples of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolvedProducts pursuant to this Umbrella Agreement before delivery to OCD. In the event that a defect is not apparent upon visual inspection during the shelf life of the Product (“Hidden Defect”), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the same, to Each lot must be accompanied by samples a certificate of analysis, as a minimum, as defined in the Quality System Agreement between SNBTS and OCD. Additional documentation requirements may be stated in a specific Product Attachment. Unless otherwise agreed upon between the parties, or as stated in a specific Product Attachment, SNBTS shall send such documentation to OCD along with delivery of Products. OCD is entitled to rely on such documentation for all purposes of this Umbrella Agreement. Nothing in this Umbrella Agreement shall be construed to require OCD to perform any Incoming Testing on any Products received from SNBTS. (C) SNBTS will retain a representative sample (the “Library Sample”) of each lot of the Products sold to OCD for the duration of time specified in the Quality System Agreement. Each Product Attachment shall specify a time period for OCD to perform Incoming Testing on the Products to determine if they conform to the Product Requirements, are free from defects in material and workmanship, and otherwise comply with the warranties set forth in Article 19.0 (Representations and Warranties) and, on the basis of such allegedly defective Productinspection, if such samples are available In accept or reject the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it shipment. OCD shall be deemed as Kitov having to have accepted the relevant consignment. 3.7.3 Dexcel shall use its best efforts to make up any shortfall in shipment quantity Products supplied by SNBTS as soon as practicable after being notified by Kitov of such shortfall. In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after receipt of the samples to show that the Product in question meets the Specifications (“Period”). In the event that no agreement is reached by the end of the Period, Kitov shall have the right to submit a new purchase order, which Dexcel shall satisfy as soon as possible using reasonable commercial efforts (“Replacement Shipment”), free from damage and Dexcel shall require proof that Kitov has destroyed that part or all of the original shipment with claimed defective Product. In the event that Kitov has fully paid the Supply Price for the claimed defective Product, Dexcel shall supply the Replacement Shipment at no additional Transfer Price. In the event that Kitov has not fully paid the Supply Price for the claimed defective Product, Kitov will pay for the Replacement Shipment defects and are in accordance with the provisions of this Agreement (assuming the Replacement Shipment meets the Specifications). 3.7.4 Dexcel’s responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement terms of the Product relevant order in all respects unless OCD notifies SNBTS of any damage, defect, or discrepancy within the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement. 3.7.5 In the event that the Parties do not agree on whether time period specified in the Product meets the Specifications by the end of the PeriodAttachment. Ortho-Clinical Diagnostics, the Parties agree to nominate an independent, reputable laboratory approved by the Regulatory Authority (“Laboratory”), acceptable to both Parties, which shall examine representative samples taken from such consignment, using the methods of analysis agreed upon by both Parties. The result shall be binding upon both Parties. Any charges for such examination shall be borne by the Party found to be wrong in its assessment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment failed to meet the Specifications, Kitov shall only have to pay Dexcel for the Replacement Shipment. In the event that Kitov receives a Replacement Shipment and the Laboratory decides that the first shipment met the Specifications, Kitov shall have to pay for both shipments.Inc. / SNBTS Proprietary Information

Appears in 1 contract

Sources: Supply Umbrella Agreement